A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: A report of the children's cancer group

Mitchell S. Cairo, Mark D. Krailo, Joel A. Weinthal, Rita Secola, Sharon Bergeron, Carmella Van De Ven, Bruce R. Blazar, Leslie Garrison, Gregory H. Reaman

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: A report of the children's cancer group'. Together they form a unique fingerprint.

Medicine & Life Sciences